Asset Management
Compare Stocks
5 / 10Stock Comparison
HLNE vs BN vs STEP vs GCMG vs ARES
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
HLNE vs BN vs STEP vs GCMG vs ARES — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $4.41B | $102.89B | $2.15B | $1.60B | $40.38B |
| Revenue (TTM) | $713M | $77.66B | $1.17B | $523M | $6.47B |
| Net Income (TTM) | $206M | $1.31B | $-547M | $34M | $527M |
| Gross Margin | 70.8% | 40.0% | -7.6% | 45.0% | 74.8% |
| Operating Margin | 44.4% | 39.9% | -21.3% | 14.0% | 27.2% |
| Forward P/E | 15.3x | 16.4x | 26.3x | 12.7x | 20.2x |
| Total Debt | $368M | $263.42B | $383M | $486M | $14.91B |
| Cash & Equiv. | $277M | $16.24B | $289M | $89M | $1.50B |
HLNE vs BN vs STEP vs GCMG vs ARES — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| Hamilton Lane Incor… (HLNE) | 100 | 143.1 | +43.1% |
| Brookfield Corporat… (BN) | 100 | 255.4 | +155.4% |
| StepStone Group Inc. (STEP) | 100 | 206.8 | +106.8% |
| GCM Grosvenor Inc. (GCMG) | 100 | 108.3 | +8.3% |
| Ares Management Cor… (ARES) | 100 | 304.2 | +204.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HLNE vs BN vs STEP vs GCMG vs ARES
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HLNE is the clearest fit if your priority is valuation efficiency.
- PEG 0.75 vs ARES's 1.15
BN carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.0% vs ARES's 0.5% (lower = leaner)
- +26.5% vs HLNE's -41.0%
- Efficiency ratio 0.0% vs ARES's 0.5%
Among these 5 stocks, STEP doesn't own a clear edge in any measured category.
GCMG is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.89, current ratio 3.07x
- Beta 0.89, yield 1.0%, current ratio 3.07x
- Lower P/E (12.7x vs 20.2x)
- Beta 0.89 vs STEP's 1.73
ARES ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 7 yrs, beta 1.62, yield 6.6%
- Rev growth 66.6%, EPS growth -5.3%
- 9.3% 10Y total return vs BN's 300.6%
- 66.6% NII/revenue growth vs BN's -9.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs BN's -9.7% | |
| Value | Lower P/E (12.7x vs 20.2x) | |
| Quality / Margins | Efficiency ratio 0.0% vs ARES's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.89 vs STEP's 1.73 | |
| Dividends | 6.6% yield, 7-year raise streak, vs HLNE's 2.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +26.5% vs HLNE's -41.0% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs ARES's 0.5% |
HLNE vs BN vs STEP vs GCMG vs ARES — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HLNE vs BN vs STEP vs GCMG vs ARES — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLNE leads in 2 of 6 categories
BN leads 1 • ARES leads 1 • STEP leads 0 • GCMG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLNE leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BN is the larger business by revenue, generating $77.7B annually — 148.3x GCMG's $523M. HLNE is the more profitable business, keeping 30.5% of every revenue dollar as net income compared to STEP's -15.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $713M | $77.7B | $1.2B | $523M | $6.5B |
| EBITDAEarnings before interest/tax | $320M | $32.1B | -$948M | $127M | $1.8B |
| Net IncomeAfter-tax profit | $206M | $1.3B | -$547M | $34M | $527M |
| Free Cash FlowCash after capex | $364M | -$2.8B | $19M | $188M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +70.8% | +40.0% | -7.6% | +45.0% | +74.8% |
| Operating MarginEBIT ÷ Revenue | +44.4% | +39.9% | -21.3% | +14.0% | +27.2% |
| Net MarginNet income ÷ Revenue | +30.5% | +1.7% | -15.3% | +3.6% | +8.2% |
| FCF MarginFCF ÷ Revenue | +43.7% | — | +5.1% | +25.2% | +23.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -56.8% | +73.1% | +40.6% | +151.6% | -80.9% |
Valuation Metrics
BN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 17.1x trailing earnings, HLNE trades at a 100% valuation discount to BN's 9999.0x P/E. Adjusting for growth (PEG ratio), HLNE offers better value at 0.84x vs ARES's 3.56x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.4B | $102.9B | $2.1B | $1.6B | $40.4B |
| Enterprise ValueMkt cap + debt − cash | $4.5B | $350.1B | $2.2B | $2.0B | $53.8B |
| Trailing P/EPrice ÷ TTM EPS | 17.08x | 9999.00x | -21.84x | 328.28x | 62.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.34x | 16.45x | 26.30x | 12.65x | 20.19x |
| PEG RatioP/E ÷ EPS growth rate | 0.84x | — | — | — | 3.56x |
| EV / EBITDAEnterprise value multiple | 13.82x | 8.49x | — | 25.93x | 26.85x |
| Price / SalesMarket cap ÷ Revenue | 6.19x | 1.32x | 1.83x | 3.05x | 6.24x |
| Price / BookPrice ÷ Book value/share | 4.77x | 0.65x | 2.21x | — | 3.07x |
| Price / FCFMarket cap ÷ FCF | 14.17x | — | 35.89x | 12.08x | 26.15x |
Profitability & Efficiency
HLNE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
GCMG delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-10 for STEP. STEP carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARES's 1.71x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs STEP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.6% | +0.8% | -9.8% | +8.9% | +6.2% |
| ROA (TTM)Return on assets | +9.5% | +0.3% | -10.4% | +5.0% | +1.9% |
| ROICReturn on invested capital | +21.2% | +5.6% | -8.7% | +15.5% | +6.1% |
| ROCEReturn on capital employed | +26.2% | +7.2% | -10.6% | +14.8% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 4 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.40x | 1.59x | 0.22x | — | 1.71x |
| Net DebtTotal debt minus cash | $91M | $247.2B | $93M | $396M | $13.4B |
| Cash & Equiv.Liquid assets | $277M | $16.2B | $289M | $89M | $1.5B |
| Total DebtShort + long-term debt | $368M | $263.4B | $383M | $486M | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | 25.57x | 1.64x | -126.38x | 6.46x | 2.68x |
Total Returns (Dividends Reinvested)
Evenly matched — STEP and ARES each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARES five years ago would be worth $26,555 today (with dividends reinvested), compared to $10,083 for GCMG. Over the past 12 months, BN leads with a +26.5% total return vs HLNE's -41.0%. The 3-year compound annual growth rate (CAGR) favors STEP at 38.5% vs HLNE's 13.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.0% | -1.5% | -17.0% | +0.7% | -25.3% |
| 1-Year ReturnPast 12 months | -41.0% | +26.5% | +5.4% | -7.9% | -20.6% |
| 3-Year ReturnCumulative with dividends | +46.1% | +122.4% | +165.5% | +60.7% | +64.5% |
| 5-Year ReturnCumulative with dividends | +11.5% | +90.7% | +81.0% | +0.8% | +165.5% |
| 10-Year ReturnCumulative with dividends | +483.9% | +300.6% | +139.9% | +37.9% | +934.1% |
| CAGR (3Y)Annualised 3-year return | +13.5% | +30.5% | +38.5% | +17.1% | +18.1% |
Risk & Volatility
Evenly matched — BN and GCMG each lead in 1 of 2 comparable metrics.
Risk & Volatility
GCMG is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than STEP's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BN currently trades 92.5% from its 52-week high vs HLNE's 51.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.25x | 1.57x | 1.73x | 0.89x | 1.62x |
| 52-Week HighHighest price in past year | $179.19 | $49.57 | $77.80 | $13.22 | $195.26 |
| 52-Week LowLowest price in past year | $86.47 | $35.95 | $40.58 | $9.30 | $95.80 |
| % of 52W HighCurrent price vs 52-week peak | +51.6% | +92.5% | +70.7% | +85.2% | +63.0% |
| RSI (14)Momentum oscillator 0–100 | 39.1 | 55.7 | 57.7 | 61.2 | 58.9 |
| Avg Volume (50D)Average daily shares traded | 852K | 5.7M | 1.1M | 536K | 3.7M |
Analyst Outlook
ARES leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HLNE as "Buy", BN as "Buy", STEP as "Buy", GCMG as "Buy", ARES as "Buy". Consensus price targets imply 113.1% upside for GCMG (target: $24) vs 18.7% for BN (target: $54). For income investors, ARES offers the higher dividend yield at 6.57% vs GCMG's 0.96%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $171.50 | $54.40 | $72.50 | $24.00 | $177.38 |
| # AnalystsCovering analysts | 10 | 9 | 8 | 8 | 22 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | — | +1.9% | +1.0% | +6.6% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 4 | 0 | 7 |
| Dividend / ShareAnnual DPS | $2.51 | — | $1.07 | $0.11 | $8.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.8% | 0.0% | 0.0% | +0.8% | 0.0% |
HLNE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BN leads in 1 (Valuation Metrics). 2 tied.
HLNE vs BN vs STEP vs GCMG vs ARES: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HLNE or BN or STEP or GCMG or ARES a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -9. 7% for Brookfield Corporation (BN). Hamilton Lane Incorporated (HLNE) offers the better valuation at 17. 1x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate Hamilton Lane Incorporated (HLNE) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HLNE or BN or STEP or GCMG or ARES?
On trailing P/E, Hamilton Lane Incorporated (HLNE) is the cheapest at 17.
1x versus Brookfield Corporation at 9999. 0x. On forward P/E, GCM Grosvenor Inc. is actually cheaper at 12. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Hamilton Lane Incorporated wins at 0. 75x versus Ares Management Corporation's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HLNE or BN or STEP or GCMG or ARES?
Over the past 5 years, Ares Management Corporation (ARES) delivered a total return of +165.
5%, compared to +0. 8% for GCM Grosvenor Inc. (GCMG). Over 10 years, the gap is even starker: ARES returned +934. 1% versus GCMG's +37. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HLNE or BN or STEP or GCMG or ARES?
By beta (market sensitivity over 5 years), GCM Grosvenor Inc.
(GCMG) is the lower-risk stock at 0. 89β versus StepStone Group Inc. 's 1. 73β — meaning STEP is approximately 94% more volatile than GCMG relative to the S&P 500. On balance sheet safety, StepStone Group Inc. (STEP) carries a lower debt/equity ratio of 22% versus 171% for Ares Management Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — HLNE or BN or STEP or GCMG or ARES?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -9. 7% for Brookfield Corporation (BN). On earnings-per-share growth, the picture is similar: GCM Grosvenor Inc. grew EPS 112. 3% year-over-year, compared to -376. 9% for StepStone Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HLNE or BN or STEP or GCMG or ARES?
Hamilton Lane Incorporated (HLNE) is the more profitable company, earning 30.
5% net margin versus -15. 3% for StepStone Group Inc. — meaning it keeps 30. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLNE leads at 44. 4% versus -21. 3% for STEP. At the gross margin level — before operating expenses — ARES leads at 74. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HLNE or BN or STEP or GCMG or ARES more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Hamilton Lane Incorporated (HLNE) is the more undervalued stock at a PEG of 0. 75x versus Ares Management Corporation's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, GCM Grosvenor Inc. (GCMG) trades at 12. 7x forward P/E versus 26. 3x for StepStone Group Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GCMG: 113. 1% to $24. 00.
08Which pays a better dividend — HLNE or BN or STEP or GCMG or ARES?
In this comparison, ARES (6.
6% yield), HLNE (2. 7% yield), STEP (1. 9% yield), GCMG (1. 0% yield) pay a dividend. BN does not pay a meaningful dividend and should not be held primarily for income.
09Is HLNE or BN or STEP or GCMG or ARES better for a retirement portfolio?
For long-horizon retirement investors, GCM Grosvenor Inc.
(GCMG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 1. 0% yield). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GCMG: +37. 9%, BN: +300. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HLNE and BN and STEP and GCMG and ARES?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HLNE is a small-cap high-growth stock; BN is a mid-cap quality compounder stock; STEP is a small-cap high-growth stock; GCMG is a small-cap high-growth stock; ARES is a mid-cap high-growth stock. HLNE, STEP, GCMG, ARES pay a dividend while BN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 32%
- Dividend Yield > 0.7%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.